USD 2.0 billion
Clinical Trial Materials And Supplies Market Size, Share, Growth Analysis, By Clinical trial type(Therapeutic & Prevention and Diagnostics), By Phase(Phase 1, phase 2, phase 3), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35B2074 |
Region:
Global |
Published Date: July, 2024
Pages:
260
|Tables:
61
|Figures:
69
Clinical Trial Materials And Supplies Market Insights
Clinical Trial Materials and Supplies Market was valued at USD 2.61 billion in 2022, and is poised to grow from USD 2.79 billion in 2023, to USD 4.76 Billion by 2031 at a CAGR of 6.90% during the forecast period (2024-2031).
Management of clinical trial supplies is necessary to prevent inventory expiration, excess supply, and overproduction. Clinical trial supplies are becoming more important since drug detection is becoming more expensive. An effective supply chain management of the pharmaceuticals is necessary for clinical research, taking into account the infrastructure's limitations and the regulations' tight enforcement. The main factors driving the market are the expansion of clinical trial studies and the growing complexity of conducting these trials. The term "clinical trial supplies" refers to a variety of instruments and apparatus used in clinical research, scientific inquiries, and experimentation. The most often utilised supplies for clinical trials are infusion pumps, nebulizers, and syringe needles. They are largely employed in the conduct of medical trials for the detection, prevention, and treatment of various diseases, the evaluation of the effectiveness of a particular therapeutic approach, and the diagnosis of various infections and metabolic illnesses. They also have a wide range of uses in cardiovascular, neurological, oncological, and pulmonary operations.
The market is growing at faster rate. Drug developers and manufacturers are now outsourcing their clinical trial supplies, which are then delivered to the investigator site, due to the rising complexity and expense of clinical studies. The demand for clinical trial materials and supplies has also increased as a result of factors such as technological developments in the clinical trial supply chain process, strategic growth among solution providers, and an increase in the number of patents expiring.
US Clinical Trial Materials And Supplies Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
phase 1
Fastest Growth
phase 1
Growth Rate
6.9% CAGR
Global Clinical Trial Materials And Supplies Market($Bn)
Country Share for Asia Pacific Region (%)
To get more reports on the above market click here to Buy The Report
Clinical Trial Materials And Supplies Market Segmental Analysis
Global clinical trial materials and supplies market is segmented based on the clinical trial type, phase and region. Based on clinical trial type, clinical trial materials and supplies market is segmented into Therapeutic & Prevention and Diagnostics. Based on phase, the clinical trial materials and supplies market is segmented into phase 1, phase 2, phase 3. Based on Region Clinical Trial Materials and Supplies Market is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Clinical Trial Materials and Supplies Market Analysis by Clinical Trial Type
Based on clinical trial type, the market is anticipated to develop at the quickest CAGR during the forecast period, with the therapeutic and prevention sector leading the pack. One of the few factors driving the therapeutic and prevention trial sector is the rising prevalence of diseases, greater concentration of biopharmaceutical businesses, and rising spending in research and development by the drug producers. Vaccines, drug development, therapeutic devices, biosimilars, therapeutic tests, and procedures make up the remaining segments of the therapeutic and prevention market. Due to the rise in the worldwide burden of disease and the occurrence of uncommon diseases, the drug development segment is anticipated to experience the fastest CAGR growth throughout the forecast period.
Clinical Trial Materials and Supplies Market Analysis by Phase
Based on phase, the phase 3 trial market will account for the greatest part of the clinical trial materials and supplies market in 2010. The significant proportion of this market is primarily attributable to the complexity of clinical supplies, the rise in phase 3 patients, and the number of successful phase 3 trials in numerous therapeutic areas.
Global Clinical Trial Materials And Supplies Market size by phase
To get detailed analysis on other segments, Request For Free Sample Report
Clinical Trial Materials And Supplies Market Regional Insights
Asia Pacific is expected to expand at the fastest CAGR of 6.9% during the forecast period. The majority of clinical trials are done in North America, which also has the largest market share. This increase is attributed to a number of factors, including the expansion of healthcare businesses performing clinical trials in the region, favourable government policy, and the accessibility of reasonably priced goods. One of the markets's fastest-growing regions is predicted to be Asia Pacific. The region's market is anticipated to increase significantly as a result of the enormous growth in clinical research. The low cost per patient in Asia Pacific nations and the availability of a broad population of patients who are simple to recruit are the main factors influencing the rise of clinical research in these regions.
Global Clinical Trial Materials And Supplies Market Size By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Clinical Trial Materials And Supplies Market Dynamics
Clinical Trial Materials and Supplies Market Driver
- In emerging countries like China, India, and South Korea, where the expense of participating in clinical trials is lower than in industrialised nations, the number of patients participating in clinical trials has increased dramatically. According to Austrade, the price of early phase clinical trials is 28% less expensive in developing nations before tax incentives and 60% less expensive aftertax incentives than in the US. Due to this, there are now many cases of uncommon diseases, and the locations of their clinical trials have been changed to poor countries. Additionally, technology and data play a key role in clinical trial decision-making. The pharma and biotech sectors are prepared to outsource these improvements to innovate existing clinical trial processes and supply systems in these developing nations thanks to the development of new technology and the rise of online communities.
Clinical Trial Materials and Supplies Market Restraint
- Due to the high attrition rate of drug candidates in development, the expenses associated with drug research and development are substantial. Drug R&D procedures can be prone to failure since R&D for some uncommon diseases is extremely difficult and necessitates a particular group of people to execute a clinical trial. Only 7 out of 100 cancer medications that make it to the clinical testing stage ultimately receive regulatory approval; the majority of medications fail well before this. The process of creating a new drug, from drug discovery to FDA approval, typically takes 10-15 years and costs USD 2.6 billion. FDA approval occurs in less than 12% of candidates who advance to Phase clinical trials. This is a significant element preventing the market from expanding.
Request Free Customization of this report to help us to meet your business objectives.
Clinical Trial Materials And Supplies Market Competitive Landscape
Global clinical trial materials and supplies market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
Clinical Trial Materials and Supplies Market Top Player's Company Profiles
- KLIFO A/S
- PAREXEL International Corporation
- Movianto GmbH
- Patheon, Inc.
- Biocair International Ltd.
- PCI Services
- Marken
- Thermo Fischer Scientific, Inc.
- Sharp Packaging Services
- Piramal Pharma Solutions
- UDG Healthcare
- EUROFINS
Clinical Trial Materials and Supplies Market Recent Developments
- In April 2021, Catalent expanded capabilities at its clinical supply services facility in Philadelphia to support sponsors developing cell and gene therapies.
- In September 2022, Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, today announced the opening of a new clinical trial supplies and logistics depot in Suzhou, China.
Clinical Trial Materials And Supplies Key Market Trends
- The quantity of biologics and temperature-sensitive medications in clinical trials has significantly increased. 35.0% of late-phase pharmaceutical medications are biologics, and 38.0% of pharmaceutical drugs are already temperature-sensitive. As the need for biologics grows due to their reduced side effects when compared to conventional ties for the storage of temperature-sensitive medications, this number is anticipated to rise in the future. The demand for cold chain facilities is therefore anticipated to increase as the number of biologics in clinical trials increases.
Clinical Trial Materials And Supplies Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our clinical trial materials and supplies market analysis, in terms of clinical trial type, the therapeutic and prevention segment held larger market share owing to rising concentration of biopharmaceutical companies. And in terms of phase, the phase 3 segment contribute to the market growth due to rising complexity of the clinical supplies along with enhanced number of patients in Phase 3. Moreover, the increasing R&D expenditure of pharmaceutical and biopharmaceutical companies drives market growth. Whereas, high cost of drug development can hamper the clinical trial materials and supplies market growth.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 2.61 billion |
| Market size value in 2031 | USD 4.76 Billion |
| Growth Rate | 6.90% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Clinical Trial Materials And Supplies Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Clinical Trial Materials And Supplies Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Clinical Trial Materials And Supplies Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Clinical Trial Materials And Supplies Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Clinical Trial Materials And Supplies Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Clinical Trial Materials And Supplies Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
